More than 100 human papillomaviruses (HPVs) have been identified and had their whole genomes sequenced. Most of these HPVs can be classified into three distinct genera, the alpha-, beta-and gamma-papillomaviruses (PVs). Of note, only one or a small number of PVs have been identified for each individual animal species. However, four canine PVs (CPVs) (COPV, CPV2, CPV3 and CPV4) have been described and their entire genomic sequences have been published. Based on their sequence similarities, they belong to three distinct clades. In the present study, circular viral DNA was amplified from three dogs showing signs of pigmented plaques, endophytic papilloma or in situ squamous cell carcinoma. Analysis of the DNA sequences suggested that these are three novel viruses (CPV5, CPV6 and CPV7) whose genomes comprise all the conserved sequence elements of known PVs. The genomes of these seven CPVs were compared in order properly classify them. Interestingly, phylogenetic analyses, as well as pairwise sequence alignments of the putative amino acid sequences, revealed that CPV5 grouped well with CPV3 and CPV4, whereas CPV7 grouped with CPV2 but neither group fitted with other classified PVs. However, CPV6 grouped with COPV, a lambda-PV. Based on this evidence, allocation of CPVs into three distinct clades could therefore be supported. Thus, similar to HPVs, it might be that the known and currently unknown CPVs are related and form just a few clades or genera.
INTRODUCTION
Papillomaviruses (PVs) are small, non-enveloped, doublestranded DNA viruses that have a tropism for the skin and mucosal membranes (Howley & Lowy, 2007) . They have been found to be innocuous inhabitants of the healthy skin but are also associated with various neoplastic diseases (Howley & Lowy, 2007) . Several PV types have a high oncogenic potential; others are known to be less oncogenic, facultatively pathogenic or thought to be apathogenic (Antonsson et al., 2000; Antonsson & Hansson, 2002; Burd, 2003; Munoz et al., 2003) .
Categorization of the PVs based on their oncogenic potential has been suggested, grouping the known viruses into high-, intermediate-and low-risk PVs (Lorincz et al., 1992; Bosch et al., 1995) . This grouping is only partly reflected in the genomic characterization of the PVs. The viruses combined in one genus based on the nucleotide sequence of the L1 open reading frame (ORF) may share very distinct features, but the biological effects of these can differ significantly (de Villiers et al., 2004) . Knowledge of the phylogenetics, the genomic organization and the biological effects taken together may be the best way of characterizing PVs.
So far more than 100 human PVs (HPVs) have been isolated, cloned and sequenced completely and many more have been partially sequenced. They group into the genera alpha-, beta-, gamma-, mu-and nu-PV. Not only HPVs but also a growing number of animal PVs have been detected in lesional and healthy skin of mammals, birds and even reptiles in recent years. It would be anticipated that, in addition to humans, each animal species might carry a large set of PV types. So far, only one or a very small number of PVs have been completely sequenced for most animal species. In very few animal species, viruses belonging to different genera have been identified. Categorization of these frequently single standing viruses is often difficult or impossible at this time, as close relatives are usually missing.
A total of four virus genomes obtained from dogs have been published to date (Delius et al., 1994; Tobler et al., 2006 Tobler et al., , 2008 Yuan et al., 2007) . These seem to belong to three different clades of which only one (lambda-PV) has been named. The possible relevance of these clades is not yet clear and their characteristics are, at present, vague.
In this study, we sequenced the DNA of three new canine papillomaviruses (CPVs) extracted from three clinically affected dogs, one of them suffering from pigmented plaques, one from an inverted papilloma and one from an in situ squamous cell carcinoma (SCC). Rolling circle amplification, restriction enzyme analysis, genomic cloning and primer-walking sequencing were applied. The new viruses CPV5, CPV6 and CPV7 were compared with the other known CPVs in terms of their genomes and genomic features, their phylogenetics and the corresponding lesions. A clear grouping of the new viruses into the three proposed clades was possible and some additional characteristics could also be identified.
METHODS
Animals and samples. CPV samples were taken from three dogs. Dog one was presented at a small animal hospital in Birkenfeld, Germany, with numerous pigmented and partially hyperkeratotic macules, papules, patches and nodules distributed over the whole body. Dog two was presented at the veterinary teaching hospital in Zurich, Switzerland, with a large plaque on the ventral throat. This plaque consisted of numerous dome-shaped papules with a central plug of keratin. Dog three was a 5-year-old male trailhound presented at the veterinary teaching hospital in Edinburgh, Scotland, with hyperkeratotic plaques on the concave faces of the pinnae.
In order to make a diagnosis, 6 mm skin biopsies were taken and sent to three different histopathology laboratories, where they were processed routinely (haematoxylin and eosin staining). Additional samples were frozen immediately after excision and were sent to the Dermatology Unit of the Vetsuisse Faculty in Zurich, Switzerland, for virological analysis. Histological analyses revealed that the samples from dogs one, two and three corresponded to canine pigmented plaques, inverted papillomas and in situ SCC, respectively.
Genome amplification and cloning. Total DNA from 25 mg tissue samples of the three dogs was isolated by using a DNeasy extraction kit (Qiagen) according to the manufacturer's recommendations. DNA (1 ml) was used for rolling circle amplification (Rector et al., 2004) , using a TempliPhi Amplification kit (General Electrics Biosciences). The protocol supplied by the manufacturer was used, with slight modifications: 1 ml of 10 mM dNTPs was added and the reaction time was prolonged to 16 h at 30 uC. Amplified DNA was digested with different restriction enzymes to compare the restriction patterns and to identify possible single cutters. Amplified DNA was cloned into pBluescript II-KS + (Stratagene) using standard procedures. Initially, the XbaI and ClaI sites, the EagI and SpeI sites and the HindIII and BamHI sites were used in cases one, two and three, respectively. The ClaI, EagI and HindIII clones, respectively, were identified as containing the complete genomes.
Sequence analysis. The nucleotide sequence of cloned DNA and precipitated rolling circle amplification product was determined commercially (Microsynth) by cycle sequencing using an ABI 377 sequencer (Applied Biosystems). The primary sequences were assembled using Contigexpress (Vector NTI Informax). Besides the CPVs, 43 PVs covering all genera and including various unclassified PVs were chosen for the pylogenetic analysis. Some PVs associated with cutaneous lesions in humans were also included. Multiple sequence alignments of the L1 protein sequences were done with Mafft [version 6.611b: Blosum 62 matrix (Katoh & Toh, 2008) ]. Aligned cDNA sequences were produced by aligning the coding sequences with the corresponding aligned amino acid sequences. Bayesian phylogeny was estimated with MrBayes (version 3.1.2: Markov Chain Monte Carlo (MCMC) with GTR substitution matrix, variable gamma rates, two runs with four chains of 1 000 000 generations; Ronquist & Huelsenbeck, 2003) . Evaluation of the MCMC and final refinements of the tree were performed with BEAST (version 1.4.8; Drummond & Rambaut, 2007) .
RESULTS

Genomes and ORFs
PV genomes are characteristically approximately 8 kb and have circular genomic organization usually containing six to eight ORFs as well as one or two non-coding-regions (NCRs) (Howley & Lowy, 2007) . To compare the genomes of the seven CPVs, they were all annotated in the same way. The genome sizes of the CPVs vary by more than 800 bp ( Fig. 1) , ranging from 7742 bp (CPV4) to 8607 bp (COPV), which is still the largest described PV genome. A comparative analysis of alpha-, beta-and gamma-HPV genome sizes showed a significant correlation between genome length and genus ( Supplementary Fig. S1 , available in JGV Online). In all CPV genomes, seven characteristic ORFs can be identified (Fig. 1) . While the ORFs of the late genes appear to be quite conserved in terms of size, certain differences can be observed among the early genes and the NCRs (Table 1) . Most prominent is the typical lambda-PV pattern with a very large second NCR (NCR2) and rather small E2 and E4 ORFs; this pattern is present in COPV and CPV6. In the case of CPV3, CPV4 and CPV5, the NCR2 is approximately 200 nt smaller, while the NCR2 of both COPV and CPV6 is at least twice as long. According to the genome size and organization, the viruses might be grouped as follows: COPV and CPV6; CPV2 and CPV7; and CPV3, CPV4 and CPV5.
Characteristic motifs
Besides the ORFs, several characteristic features that are predicted to play a role in the PV life cycle are known at the nucleotide and amino acid level (Androphy et al., 1987; Howley & Lowy, 2007; Münger et al., 2004; Wilson et al., 2002) . All CPV sequences were scanned to identify these putative sites and the analysis revealed typical features in the genomes of all seven sequences ( Supplementary Table  S1 , available in JGV Online). The GC content of the entire genomes is 40-53 %. The clade comprising CPV3, CPV4 and CPV5 shows the highest GC content, with 51, 53 and 50 %, respectively. Besides transcription factor binding sites for SP1 and NF1 and the TATA signals, the sequence elements for PV DNA replication were found in all seven viral genomes. In particular, a dyad symmetry repeat flanked by two E2 binding sites is present on each genomic sequence within the NCR1. Examination of the putative protein sequences reveals an ATP-dependent helicase motif located in each E1 and two and one metal-binding motifs in E6 and E7, respectively.
Sequence analysis and comparison
In order to evaluate the possible classification of the three newly recognized canine PVs, phylogeny based on the L1 sequences was determined. Amino acid sequences of 50 L1 proteins, including those from the three newly recognized canine PVs, were aligned; the alignment was then backtranslated into the nucleotide sequences and used to infer the phylogeny of the 50 PVs (Fig. 2) . Based on the resulting tree, CPV3, CPV4 and CPV5 are located on one clade of the tree close to bovine PV (BPV)-1 and ovine PV-1 (delta-PV) and BPV5 (epsilon-PV) and Equus caballus PV1 (zeta-PV). Likewise, CPV7 neighbours CPV2 and is in proximity to HPV4 and HPV50 (gamma-PV), and CPV6 neighbours Felis domesticus PV1 and COPV (lambda-PV). In conclusion, each of the three newly recognized canine PVs is related to one previously described canine PV.
In order to investigate the relatedness of the canine PVs further, pairwise alignments were performed for each individual protein sequence of each virus against all other viruses ( Table 2) only around 50 % (46-54 %) identity. Throughout most protein alignments, CPV3, CPV4 and CPV5 revealed higher intra-clade identities than the other two proposed clades of COPV and CPV6 or CPV2 and CPV7. The E2 of CPV4 is less identical to the one of CPV3 and CPV5 than E2 of COPV is to that of CPV6. Likewise, the L1 of CPV4 is less identical to the one of CPV3 and CPV5 than L1 of COPV is to that of CPV6 or than L1 of CPV2 is to that of CPV7. In conclusion, the pairwise amino acid alignments support the classification of the canine PVs into three clades.
Associated clinical conditions
The association of PVs with certain clinical signs is of special interest. The corresponding information from the previously published and the novel cases was assembled and analysed (Table 3) . CPV3, CPV4 and CPV5 appear to be similar as they are all associated with pigmented plaques that are of a persistent character. COPV and CPV6 were mainly found to be associated with self-regressing lesions. A certain grouping of viruses in terms of their associated clinical conditions seems to be present. Fig. 2 . Neighbour-joining phylogenetic tree of the L1 nucleotide sequences of 50 PVs. The PV genus of each strain is indicated. PVs and/or putative PV genera that are currently unclassified are marked with an asterisk. The PVs (with their GenBank accession nos) are: BPV1 (NC_001522), BPV3 (NC_004197), BPV5 (NC_004195), BPV6 (AJ620208); bandicoot papillomatosis carcinomatosis PV (BPCV1) (NC_010107); COPV (NC_001619); CPV2 (NC_006564), CPV3 (NC_008297), CPV4 (NC_010226), CPV5 (FJ492743), CPV6 (FJ492744), CPV7 (FJ492742); Capra hircus PV (ChPV1) (NC_008032); Erethizon dorsatum PV (EdPV1) (AY684126); Equus caballus PV (EcPV1) (NC_003748); Fringilla coelebs PV (FcPV1) (NC_004068); Felis domesticus PV (FdPV1) (NC_004765), FdPV2 (EU796884); hamster oral PV (HaOPV1) (E15111); HPV1 (NC_001356), HPV3 (NC_001588), HPV4 (NC_001457), HPV5 (NC_001531), HPV9 (NC_001596), HPV12 (X74466), HPV13 (NC_001349), HPV14 (X74467), HPV15 (NC_001579), HPV16 (NC_001526), HPV17 (X74469), HPV18 (NC_001357), HPV20 (U31778), HPV21 (U31779), HPV32 (X74475), HPV41 (NC_001354), HPV50 (NC_001691), HPV63 (NC_001458); Lynx rufus PV (LrPV1) (AY904722); Mastomys natalensis PV (MnPV1) (NC_001605); ovine PV (OvPV1) (NC_001789); Puma concolour PV (PcPV1) (AY904723); Psittacus erithacus PV (PePV1) (NC_003973); Procyon lotor PV (PlPV1) (AY763115); Panthera leo persica PV (PlpPV1) (AY904724); Phocoena spinipinnis PV (PsPV1) (NC_003348); rabbit oral PV (ROPV) (NC_002232); Rousettus aegyptiacus PV (RaPV1) (NC_008298); Trichechus manatus latirostris PV (TmlPV1) (NC_006563); Ursus maritimus PV (UmPV1) (NC_010739); Uncia uncia PV (UuPV1) (DQ180494). Numbers at internal nodes represent the posterior probability support values. Only posterior probabilities above 0.5 are shown.
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DISCUSSION
PVs are known to exist with a relatively large genetic variety in humans, but so far the whole genomes of only four CPVs, which group into three distinct clades, have been published. The latter finding supported the hypothesis that there might be a broad variety of CPVs as well.
Here, we compared the genomic sequences, features, phylogenetics and disease-associations of these four CPVs with those of three novel PVs in order to gain a better overall picture of CPVs and their characteristics. We identified not only the typical lambda-PV features, such as a large NCR2 in the case of COPV and CPV6, but also possible characteristics of the two other proposed CPV clades.
The size of the CPV genomes was found to differ among the three proposed CPV clades. Those of the lambda-PVs were, as lambda-PVs are in general, the longest. The sequences of CPV2 and CPV7 were still long but clearly shorter than the lambda-PVs. The shortest and, in terms of length, the least varying genomic sequences, were found among the clade of CPV3. This appears to be a parallel to HPVs of the genera alpha, beta and gamma ( Supplementary Fig. S1 ). Size trends could also be seen in all the coding and non-coding regions of the CPV genomes with the most prominent difference seen in the lambda-PVs, where the NCR2 was longest and E2 and E4 were shortest. It is not clear what kind of biological effects may be associated with these, in several cases significant, size differences of the genomes and ORFs. The differences, nevertheless, seem to be mainly clade specific, in analogy to findings in HPVs. However, some trends recognized in HPVs do not seem to be present in CPVs, namely the association of low GC content and a small E2 ORF with a high risk of developing tumours. As only very few members in each proposed CPV clade have been recognized, these trends remain unclear and need to be reconsidered whenever new viruses grouping into these clades are discovered.
The phylogenetic analysis of the CPVs in comparison with other PVs grouped the seven CPVs into three proposed clades. The positions of the clades could be confirmed, but the posterior probability support of the Bayesian phylogeny of the canine clades remains limited, as not many closely related PVs are currently known. This finding nevertheless further supports the hypothesis that animals, like humans, harbour their own set of PVs, which group into different genera that have different characteristics. This hypothesis Three novel canine papillomaviruses previously arose from the discovery of several BPVs (Campo et al., 1981; Jarrett et al., 1984; Claus et al., 2008; Hatama et al., 2008; Ogawa et al., 2007; Tomita et al., 2007) and recently from the discovery of some CPVs (Tobler et al., 2006 (Tobler et al., , 2008 Yuan et al., 2007) . The clade including CPV3, CPV4 and CPV5 as well as the clade including CPV2 and CPV7 should consequently be regarded as genera even though they might temporarily remain unnamed. It can be anticipated that several CPVs that are yet to be discovered will group into these three proposed genera. The discovery of CPVs grouping into other possibly new clades can also be expected, since fragments of PVs, which may not fit into the present clades, were previously found in canine lesions (Zaugg et al., 2005) .
Phylogenetic classification of HPVs only partially correlates with clinical presentation (Howley & Lowy, 2007) . Similarly, the putative classification of CPVs (Table 3) does not unanimously link with the clinical consequences of infection. Nevertheless, some features seem to be characteristic for some clades. CPV3, CPV4 and CPV5 were extracted from dogs suffering from persisting pigmented plaques and might be associated with these signs of disease. COPV and CPV6 might be associated with transient endophytic or exophytic proliferation but also with asymptomatic infection (unpublished data).
In conclusion, the genomic analysis of three novel CPVs proposes their classification into three distinct genera. The putative characteristics of these genera may be applied to classify other currently unknown CPVs. Their sequences and biological properties might disclose the true nature of PV infections in dogs.
